PMI Reports Strong Performance for Q2 and First Half2024

Jul.24.2024
PMI Reports Strong Performance for Q2 and First Half2024
PMI announces strong 2024 Q2 and first half results with net income and operating revenue growth.

On July 23, Philip Morris International (PMI) (NYSE: PM) announced its financial results for the second quarter and first half of 2024. The company posted a net revenue of $9.5 billion in Q2, a 5.6% increase from the same quarter in 2023, with a gross profit of $6.1 billion, a 6.7% increase from Q2 of 2023. Operating income also saw a year-over-year increase of 34.2% to $3.44 billion. For the first half of the year, net revenue was $18.261 billion, and operating income increased by 22.5% to $6.489 billion compared to the same period in 2023.

PMI Reports Strong Performance for Q2 and First Half2024
Translation: PMI Q2 operational review. Source: PMI official website.


In the second quarter, the PMI shipment volume was 197.3 billion units, including 157.6 billion cigarettes, 35.5 billion heated tobacco products, and 4.2 billion orally consumed smokeless products (the sales volume of orally consumed smokeless products does not include snuff, snuff leaves, and chewing tobacco). The smokeless business accounted for 38.1% of the company's total quarterly revenue, an increase of 2.7% from the same period in 2023. Oral smokeless products experienced strong growth, with an increase of over 20% compared to the second quarter of last year. In the six months so far this year, the shipment volume of heated tobacco products was 68.678 billion, and the total shipment volume of canned oral products was 486 million cans, an increase of 31.2% from the same period in 2023.

PMI Reports Strong Performance for Q2 and First Half2024
Translation: PMI first half year operation review Source: PMI official website


The performance highlights are as follows: In the e-cigarette category, VEEV has taken the top position in the closed pod segment market in 5 European markets within 12 months of its launch. Smoke-Free Products (SFB): Net revenue increased by 13.6%, gross profit increased by 15.6%, accounting for 38.1% of total net revenue, a year-on-year increase of 2.7%; expected 36.5 million adult users, with these products available in 90 markets. Smoke-Free Oral Products (SFP2): Can shipments increased by 23.5%, mainly driven by the growth of the ZYN nicotine pouch in the U.S., with shipments reaching 135.1 million cans, a 50.3% increase compared to the previous year. Outside the U.S., nicotine pouch sales increased by over 50%, particularly in some new markets like Pakistan. Smoke-Free Nicotine Products (SFP): As of the end of the quarter, the total estimated users of IQOS were 30.8 million, benefiting from significant progress with the launch of ILUMA i in Japan, Europe (especially in Greece, Hungary, Romania, Bulgaria, and Spain), Korea, and middle- to low-income markets (especially Indonesia). Combustible products: Net revenue increased by 1.2% (organic growth of 4.8%), thanks to another high single-digit pricing and stable industry volume quarter. Dividends: Regular quarterly dividend of $1.30 per share, annualized at $5.20 per share. Diluted earnings per share for the second quarter increased by 52.5% to $1.54 adjusted diluted earnings per share decreased by 0.6% to $1.59 per share; excluding exchange rate effects, it increased by 10.6%.


In the second quarter, total shipments of PMI cigarettes and HTU increased by 2.5%, while total shipments of canned oral products grew by 23.5%, mainly due to the increase in sales of nicotine pouch products.


In Japan, the IQOS series has shown impressive performance, with IQOS increasing its market share in the heated tobacco market by 3% to over 29%.


In the European region, the total market volume of cigarettes and HNB products in the second quarter is estimated to have decreased by 1.7%, to 138 billion units; for the first six months of this year, the decrease is 1.2%, to 262.1 billion units.


In the SSEA, CIS, and MEA regions, the total market volume of cigarettes and HNB products is expected to increase by 3.7% to reach 393.9 billion units. In the first six months of this year, the total market volume of this category is expected to increase by 2.5% to reach 767 billion units.


In the Americas, net income organic growth increased by 14.2%, primarily driven by ZYN nicotine pouches. In the second quarter, shipments of oral products grew by 35.8%, with ZYN nicotine pouches increasing by 50.3%. In the first six months of this year, shipments of oral products grew by 43.4%, with ZYN nicotine pouches growing by 63.5%.


According to PMI's forecast, the global industry for tobacco and tobacco products is expected to remain relatively stable in 2024, with a strong performance in the second half of the year driven by smokeless products. PMI's shipments of cigarettes, heated tobacco units (HTU), and oral smokeless products are projected to increase by 1% to 2%. Nicotine pouch shipments are estimated to range from 5.6 billion to 5.8 billion cans. Net revenues are expected to organically grow by 7.5% to 9%, while organic operating income is anticipated to increase by 11% to 13%. Capital expenditures are estimated to be around $1.3 billion to $1.4 billion, including further investments in ZYN to increase production capacity.


The CEO of PMI, Jacek Olczak, stated that...


Our smoke-free business continued to demonstrate strong momentum in the second quarter and first half of the year,


Excellent foundational performance combined with proactive measures in all categories have once again exceeded our expectations, propelling our business towards strong targets for 2024. Despite facing resistance from exchange rates, we have raised our full-year guidance.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Argentina Issues Resolution 549/2026 to Regulate Vapes, Heated Tobacco and Nicotine Pouches
Argentina Issues Resolution 549/2026 to Regulate Vapes, Heated Tobacco and Nicotine Pouches
Argentina’s government has created a comprehensive regulatory framework for nicotine products, including vapes, heated tobacco and nicotine pouches, through Resolution 549/2026 published in the Official Gazette. The new regulation ends the previous prohibitive framework and establishes rules to organize the market by requiring traceability, quality standards and mandatory registration for all manufacturers and retailers operating in the country.
May.06 by 2FIRSTS.ai
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
A report by KFF Health News says that as the Trump administration pursued a series of policies favorable to the nicotine and tobacco industry, President Donald Trump increased his holdings in tobacco companies while benefiting from substantial industry-linked political donations, prompting questions from public health advocates about potential conflicts of interest and regulatory direction.
Jun.12
Special Report|Haypp’s Nicotine Pouch Volumes Rise 40%: Who Controls the Digital Shelf for Modern Oral?
Special Report|Haypp’s Nicotine Pouch Volumes Rise 40%: Who Controls the Digital Shelf for Modern Oral?
Haypp Group reported a 40% year-on-year increase in nicotine pouch volumes in the first quarter of 2026, with U.S. and U.K. volumes rising 123% and 102%, respectively. Haypp says around 97% of its consumer traffic is organic and that its Media & Insights business provides brand owners with on-site visibility, trial activation and consumer intelligence. For international tobacco companies, Haypp may be both a growth partner for modern oral products and a new source of channel leverage.
Special Report
May.22
 BAT Bangladesh Cigarette Sales Fall 14%, Q1 Profit Drops 34%
BAT Bangladesh Cigarette Sales Fall 14%, Q1 Profit Drops 34%
British American Tobacco Bangladesh reported a 14% year-on-year decline in cigarette sales volume and a 34% drop in first-quarter profit, highlighting mounting pressure from inflation, taxation, and weakening consumer spending in Bangladesh.
News
May.18
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.
May.09 by 2FIRSTS.ai
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.
May.08 by 2FIRSTS.ai